38 Participants Needed

Aerobic Exercise for Cancer

Recruiting at 11 trial locations
LJ
JS
Overseen ByJessica Scott, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This study is being done to answer the following question: Will aerobic exercise (exercise that stimulates and strengthens the heart and lungs, and improves the body's use of oxygen) change the biomarkers (signs of disease) found in the blood?

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, you cannot be on any form of antitumor therapy, except for certain allowed therapies like endocrine therapy and anti-HER2 antibodies.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, you cannot be on any antitumor therapy, except for certain allowed treatments like endocrine therapy and anti-HER2 antibodies.

What data supports the effectiveness of the treatment Exercise, Physical Activity, Workout, Fitness Training for cancer patients?

Research shows that aerobic exercise can help cancer patients by reducing physical limitations, improving quality of life, and helping them recover physical function. It is also considered safe and beneficial for patients undergoing cancer treatment, including those with advanced cancer.12345

What data supports the effectiveness of the treatment Exercise, Physical Activity, Workout, Fitness Training for cancer patients?

Research shows that aerobic exercise can help cancer patients by reducing fatigue, improving physical function, and enhancing quality of life. It is considered safe and beneficial for patients during and after cancer treatment, helping them recover and maintain an active lifestyle.12345

Is aerobic exercise safe for cancer patients during treatment?

Research shows that aerobic exercise is generally safe for cancer patients, even during treatment. Some studies have reported a few adverse events (unwanted effects), but these are not common, and exercise can help improve quality of life and physical function.36789

Is aerobic exercise safe for cancer patients during treatment?

Research shows that aerobic exercise is generally safe for cancer patients, even during treatment. While some adverse events (unwanted effects) have been reported, they are not common, and exercise can help improve quality of life and physical function.36789

How does aerobic exercise as a treatment for cancer differ from other treatments?

Aerobic exercise is unique because it helps cancer patients improve their physical function and quality of life by reducing fatigue and other side effects of cancer and its treatment. Unlike traditional medical treatments, it focuses on enhancing physical and emotional well-being through regular physical activity.310111213

How does aerobic exercise as a treatment for cancer differ from other treatments?

Aerobic exercise is unique because it helps cancer patients improve their physical function and quality of life by reducing fatigue and other side effects of cancer and its treatment. Unlike traditional medical treatments, it focuses on enhancing physical activity and rehabilitation, making it a supportive therapy that can be used alongside other cancer treatments.310111213

Research Team

Exercise Oncology Program: Lee Jones ...

Lee Jones, PhD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Eligibility Criteria

This trial is for adults who have had or are having androgen deprivation therapy, breast cancer with stable disease or no evidence of disease, high risk of cardiovascular disease, stage III colorectal or breast cancer post-therapy, localized prostate cancer under active surveillance, Lynch syndrome without intense exercise habits. Exclusions include severe heart/lung conditions, mental impairment affecting cooperation, other conflicting trials.

Inclusion Criteria

My breast cancer has not worsened for 6 months and I'm not on chemotherapy.
I am at high risk for heart disease.
Performing less than 150 minutes of structured moderate-intensity or strenuous-intensity exercise per week, as evaluated by self-report
See 23 more

Exclusion Criteria

You have a current health condition that could affect your ability to exercise.
I have a heart rhythm problem that affects my daily activities or blood pressure.
I have fluid in my lungs.
See 18 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive structured exercise therapy for 24 weeks, consisting of individualized walking delivered up to 5 times weekly, monitored via telemedicine.

24 weeks
Home-based exercise monitored via telemedicine

Follow-up

Participants are monitored for changes in biomarkers and residual tumor burden after treatment

2 years

Treatment Details

Interventions

  • Exercise
Trial Overview The study investigates if aerobic exercise like walking can alter blood biomarkers in patients with various cancers. Participants will engage in structured exercises and provide blood samples to track changes.
Participant Groups
5Treatment groups
Experimental Treatment
Group I: post treatment patients with breast or colorectal cancerExperimental Treatment3 Interventions
Exercise treatment will consist of individualized walking delivered up to 5 times weekly. Patients in all cohorts will receive one dose of exercise (i.e., \~300 mins/wk following a non-linear dosing schedule) in both cohorts. Patients will have the option to receive exercise treatment at MSK or at their residence. Home-based exercise will be implemented and monitored using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service
Group II: patients with clonal hematopoiesisExperimental Treatment2 Interventions
Exercise treatment will consist of individualized walking delivered up to 5 times weekly. Patients in all cohorts will receive one dose of exercise (i.e., \~300 mins/wk following a non-linear dosing schedule) in both cohorts. Patients will have the option to receive exercise treatment at MSK or at their residence. Home-based exercise will be implemented and monitored using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service
Group III: men with localized prostate cancer undergoing active surveillanceExperimental Treatment3 Interventions
Exercise treatment will consist of individualized walking delivered up to 5 times weekly. Patients in all cohorts will receive one dose of exercise (i.e., \~300 mins/wk following a non-linear dosing schedule) in both cohorts. Patients will have the option to receive exercise treatment at MSK or at their residence. Home-based exercise will be implemented and monitored using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service
Group IV: Individuals with Lynch SyndromeExperimental Treatment3 Interventions
Exercise treatment will consist of individualized walking delivered up to 5 times weekly. Patients in all cohorts will receive one dose of exercise (i.e., \~300 mins/wk following a non-linear dosing schedule) in both cohorts. Patients will have the option to receive exercise treatment at MSK or at their residence. Home-based exercise will be implemented and monitored using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service
Group V: Individuals enrolled on Early Drug Development (EDD) trialsExperimental Treatment1 Intervention
Participants will receive structured exercise therapy for 24 weeks. Participants will be followed by standard of care clinical follow-up

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+

Weill Medical College of Cornell University

Collaborator

Trials
1,103
Recruited
1,157,000+

University of California, Los Angeles

Collaborator

Trials
1,594
Recruited
10,430,000+

Findings from Research

A 6-week aerobic exercise program significantly improved physical performance in five cancer patients, increasing their maximum walking speed and distance, while also reducing fatigue levels.
The exercise regimen, which involved daily treadmill walking at a specific intensity, allowed all participants to resume normal daily activities without substantial limitations, highlighting its potential as a therapeutic intervention for cancer-related fatigue.
Aerobic exercise as therapy for cancer fatigue.Dimeo, F., Rumberger, BG., Keul, J.[2022]
Exercise training is a safe and well-tolerated adjunct therapy for cancer patients, showing potential to reduce treatment-related side effects during and after adjuvant therapy.
Current evidence suggests that incorporating exercise into the care plan for cancer survivors may enhance their overall management, although further research is needed to fully understand its benefits across different stages of cancer survivorship.
Exercise therapy in the management of solid tumors.Jones, LW., Peppercom, J., Scott, JM., et al.[2021]
Aerobic exercise is an effective additive treatment for cancer patients, helping to alleviate physical limitations and improve quality of life during and after oncological treatment.
Research indicates that aerobic exercise is feasible even for patients with advanced cancer, enabling them to recover physical function and return to a more active lifestyle.
[Aerobic endurance training for cancer patients].Crevenna, R., Zielinski, C., Keilani, MY., et al.[2019]

References

Aerobic exercise as therapy for cancer fatigue. [2022]
Exercise therapy in the management of solid tumors. [2021]
[Aerobic endurance training for cancer patients]. [2019]
Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial. [2022]
Exercise in cancer. [2021]
Adverse Events Reporting of Clinical Trials in Exercise Oncology Research (ADVANCE): Protocol for a Scoping Review. [2022]
Is it safe to exercise during oncological treatment? A study of adverse events during endurance and resistance training - data from the Phys-Can study. [2021]
A systematic review of the safety and efficacy of aerobic exercise during cytotoxic chemotherapy treatment. [2021]
Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis. [2022]
Exercise can help to alleviate the fatigue associated with cancer. [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial. [2023]
Effectiveness of aerobic exercise on upper limb function following breast cancer treatment: a systematic review and meta-analysis. [2021]
Synchronized Pedaling with Martial Arts Improves Quality of Life of Women with Breast Cancer. [2018]